ALGN vs XRAY vs DDD Stock Comparison

Align Technology, Dentsply Sirona and 3D Systems Prices as of Nov 13, 2026 Peers: Industry group
ALGN Align Technology Inc
$168.32 +16.5% 1M +20.7% 1Y
Market cap
$11.90B
P/E
24.2x
Revenue (TTM)
$4.16B
Div. yield
–
Dental Healthcare
7 wins
XRAY DENTSPLY SIRONA Inc.
$9.16 +8.5% 1M -16.3% 1Y
Market cap
$1.79B
P/E
–
Revenue (TTM)
$3.58B
Div. yield
–
Dental Healthcare
2 wins
DDD 3D Systems Corp
$1.53 -47.6% 1M -29.2% 1Y
Market cap
$240.29M
P/E
–
Revenue (TTM)
$395.70M
Div. yield
–
3D Printing Industrials
1 win

Head to Head

10 decided of 12

Align Technology leads on 7 of the 12 questions below (Align Technology 7, Dentsply Sirona 2, 3D Systems 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionALGNXRAYDDDLeader
Larger companyMarket capitalisation $11.90B $1.79B $240.29M ALGN
Cheaper on earningsLower P/E, profitable companies only 24.2x -14.8x -3.4x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.5x 6.8x — XRAY
Faster revenue growthRevenue growth, trailing twelve months +4.4% -1.4% +1.0% ALGN
More profitableNet margin, trailing twelve months 11.8% -3.4% -17.8% ALGN
Better return on capitalReturn on invested capital — -1.5% -18.3% XRAY
Less leveragedLower net debt / EBITDA — 7.1x 0.6x DDD
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +20.7% -16.3% -29.2% ALGN
Better 5-year returnAnnualised price return, 5 years -24.6%/yr -30.1%/yr -43.1%/yr ALGN
Less volatileAnnualised volatility, 1 year 40.3% 48.1% 95.8% ALGN
Higher overall scoreMean of the five percentile scores vs peers 70/100 63/100 27/100 ALGN

Percentile Scorecard

ALGNXRAYDDD

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisALGNXRAYDDD
Valuation 85 #37 of 243 93 #17 of 243 28 #152 of 210
Growth 38 #142 of 228 51 #112 of 228 42 #115 of 196
Profitability 87 #29 of 222 67 #73 of 222 11 #176 of 197
Financial Health 48 #130 of 248 15 #211 of 248 54 #104 of 223
Shareholder Returns 92 #13 of 158 86 #23 of 158 1 #160 of 162
Overall 70 63 27
  • ALGN ranked among 252 companies in Medical Devices and Diagnostics
  • XRAY ranked among 252 companies in Medical Devices and Diagnostics
  • DDD ranked among 225 companies in Machinery

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodALGNXRAYDDDSPY
1 month +16.5%+8.5%-47.6% -2.0%
3 months -7.2%-21.0%-58.8% -2.8%
6 months +7.0%-9.0%-49.3% +2.0%
Year to date +7.8%-19.9%-13.6% +10.6%
1 year +20.7%-16.3%-29.2% +12.2%
3 years -17.0%-68.3%-67.3% +68.1%
3 years, per year -6.0%-31.9%-31.1% +18.9%
5 years -75.5%-83.3%-94.0% +61.4%
5 years, per year -24.6%-30.1%-43.1% +10.1%
10 years +83.9%-84.8%-89.6% +248.5%
10 years, per year +6.3%-17.2%-20.3% +13.3%

Risk

MeasureALGNXRAYDDDSPY
Volatility, 1Y 40.3%48.1%95.8% 13.6%
Downside volatility, 1Y 37.6%45.6%97.6% 13.9%
Beta vs S&P 500, 1Y 1.331.173.52 1.00
Return / volatility, 1Y 0.51-0.34-0.30 0.90
Max drawdown, 5Y -82.0%-85.7%-94.7% -25.4%
From 52-week high -14.8%-37.6%-60.6% -3.2%
52-week high $197.51$14.68$3.88 $779.14
52-week low $132.28$8.42$1.53 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleALGNXRAYDDD
P/E now vs peer median 24.3xmedian 26.5x -15.1xmedian 26.5x -3.5xmedian 24.6x
P/S now vs peer median 2.9xmedian 2.7x 0.5xmedian 2.7x 0.6xmedian 1.8x
EV/EBITDA now vs peer median 12.5xmedian 18.4x 13.5xmedian 18.4x -5.4xmedian 13.7x
P/FCF now vs peer median 19.7xmedian 25.4x 17.6xmedian 25.4x -6.0xmedian 21.9x
P/B now vs peer median 2.8xmedian 2.5x 1.3xmedian 2.5x 1.0xmedian 2.2x
PEG now vs peer median 1.78median 0.98 -0.97median 0.98 -0.22median 1.08

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsALGNXRAYDDD
Revenue $4.16B $3.58B $395.70M
Gross profit $2.88B $1.81B $136.36M
Operating income $620.46M -$55.00M -$64.44M
Net income $491.87M -$122.00M -$70.33M
Free cash flow $602.50M $103.00M -$42.46M
R&D $377.60M $171.00M $41.64M
EPS (diluted) $6.93 $-0.61 $-0.43
Cash & equivalents $1.14B $195.00M $91.34M
Total debt – $2.20B $91.80M
Shares (diluted) 71.02M 199.20M 162.91M
Enterprise value $7.49B $841.80M -$186.78M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricALGNXRAYDDD
P/E 24.3x -15.1x -3.5x
P/FCF 19.7x 17.6x -6.0x
P/Operating cash flow 15.9x 6.7x -7.9x
P/S 2.9x 0.5x 0.6x
P/B 2.8x 1.3x 1.0x
P/Tangible book 2.8x 3.4x 1.1x
EV/EBITDA 12.5x 13.5x -5.4x
EV/EBIT 17.3x -69.5x -3.5x
EV/Revenue 2.6x 1.1x 0.6x
EV/FCF 17.8x 37.1x -5.4x
EV/Operating cash flow 14.3x 14.0x -7.1x
PEG (3Y EPS CAGR) 1.78 -0.97 -0.22

Growth

14 metrics
MetricALGNXRAYDDD
Revenue growth (1Y) 4.4% -1.4% 1.0%
Revenue CAGR (3Y) 3.0% -3.2% -7.9%
Gross profit growth (1Y) 5.5% -2.0% 2.7%
Gross profit CAGR (3Y) 2.7% -4.6% -13.0%
Operating income growth (1Y) 16.1% 93.1% 37.9%
Operating income CAGR (3Y) 2.0% 16.1% 15.5%
Net income growth (1Y) 30.0% 86.2% -541.2%
Net income CAGR (3Y) 10.7% 17.7% 9.8%
EPS growth (1Y) 32.6% 86.3% -444.7%
EPS CAGR (3Y) 13.6% 15.6% 16.2%
Operating cash flow growth (1Y) 14.3% 23.1% 60.2%
Operating cash flow CAGR (3Y) -5.3% -8.8% 28.9%
Free cash flow growth (1Y) 6.3% 28.8% 54.9%
Free cash flow CAGR (3Y) -4.2% -22.1% 28.1%

Profitability

14 metrics
MetricALGNXRAYDDD
Gross margin 69.1% 50.5% 34.5%
EBITDA margin 20.6% 7.9% -10.6%
Operating margin 14.9% -1.5% -16.3%
Pretax margin 15.5% -2.5% -14.7%
Net margin 11.8% -3.4% -17.8%
FCF margin 14.5% 2.9% -10.7%
Operating cash flow margin 18.0% 7.6% -8.1%
Return on equity 11.5% -9.0% -27.1%
Return on assets 7.6% -2.3% -13.3%
Return on invested capital – -1.5% -18.3%
Return on capital employed 13.6% -1.4% -15.8%
Asset turnover 0.6x 0.7x 0.7x
Cash conversion (OCF / net income) 1.5x -2.2x 0.5x
Stock comp / revenue 4.1% 0.9% 3.4%

Financial Health

11 metrics
MetricALGNXRAYDDD
Debt / assets – 42.4% 17.5%
Debt / equity – 1.6x 0.4x
Net debt / EBITDA – 7.1x 0.6x
Debt / FCF – 21.4x -2.2x
Liabilities / assets 34.0% 73.9% 53.1%
Equity / assets 66.0% 26.1% 46.9%
Interest coverage – -0.6x -7.6x
Current ratio 1.4x 1.6x 2.9x
Quick ratio 1.2x 0.7x 1.7x
Cash ratio 0.6x 0.2x 1.0x
Altman Z-score 4.89 0.70 -2.25

Shareholder Returns

7 metrics
MetricALGNXRAYDDD
Dividend yield – 1.7% –
Net buyback yield 2.3% 0.7% -20.9%
Shareholder yield 2.3% 2.5% -20.9%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusALGNXRAYDDD
Forward P/E 15.5xFY2026 6.8xFY2026 –
EPS, next fiscal year $10.86FY2026 $1.35FY2026 $-0.15FY2026
EPS growth, next FY +3.3%FY2026 -15.6%FY2026 –
EPS growth, the year after +16.6% -1.5% –
Revenue, next fiscal year $3.84BFY2026 $3.63BFY2026 $366.61MFY2026
Revenue growth, next FY -4.7%FY2026 -1.4%FY2026 -5.2%FY2026
Revenue growth, the year after +3.1% +1.0% +7.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersALGNXRAYDDD
Held by institutions 100.0% 100.0% 71.1%
Institutions holding 678 378 210
Change in shares held, QoQ +4.2% +6.1% +34.8%
Institutions buying 293 207 126
Institutions selling 268 116 37
Buyers to sellers 1.09 1.78 3.41

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ALGNXRAYDDD
ALGN 1.00 0.60 0.20
XRAY 0.60 1.00 0.17
DDD 0.20 0.17 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ALGN, XRAY and DDD?

Align Technology (ALGN) is the largest by market capitalisation: Align Technology (ALGN) $11.90B, Dentsply Sirona (XRAY) $1.79B, 3D Systems (DDD) $240.29M.

Which company is growing faster?

Align Technology (ALGN) grew revenue fastest over the trailing twelve months: Align Technology (ALGN) +4.4%, Dentsply Sirona (XRAY) -1.4%, 3D Systems (DDD) +1.0%.

Which company is more profitable?

Align Technology (ALGN) has the highest net margin (Align Technology (ALGN) 11.8%, Dentsply Sirona (XRAY) -3.4%, 3D Systems (DDD) -17.8%). On return on invested capital, Dentsply Sirona (XRAY) leads (Dentsply Sirona (XRAY) -1.5%, 3D Systems (DDD) -18.3%).

Which stock has performed better?

Over the past year Align Technology (ALGN) returned the most: Align Technology (ALGN) +20.7%, Dentsply Sirona (XRAY) -16.3%, 3D Systems (DDD) -29.2%. Over five years, Align Technology (ALGN) compounded fastest (Align Technology (ALGN) -24.6%/yr, Dentsply Sirona (XRAY) -30.1%/yr, 3D Systems (DDD) -43.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Align Technology (ALGN) has been the steadiest (Align Technology (ALGN) 40.3%, Dentsply Sirona (XRAY) 48.1%, 3D Systems (DDD) 95.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ALGN, XRAY and DDD?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Align Technology (ALGN) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.